REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/26/2025
Back to search
Official data from USPTO
NAMVONA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
05/27/2025
Trademark type
Word
Nice classes
5
Filing date
04/11/2019
Registration date
05/26/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/26/2020
Last transaction
05/27/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Stevenage, GB
Examiner
TANNER, MICHAEL
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Glaxo Group Limited
Glaxo Group Limited
Representatives
Elizabeth K. Rucki GSK
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Vaccines
Publications
History of USPTO decisions and trademark events.
35 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/06/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/06/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/26/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2020
PUBO
PUBLISHED FOR OPPOSITION
03/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/19/2020
RPUB
NOA CANCELLED; REPUBLICATION REQUIRED
02/03/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
02/03/2020
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
01/31/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/30/2020
EX1G
SOU EXTENSION 1 GRANTED
01/28/2020
EXT1
SOU EXTENSION 1 FILED
01/28/2020
EEXT
SOU TEAS EXTENSION RECEIVED
01/28/2020
ERTI
TEAS RESPONSE TO PETITION INQUIRY LETTER
12/06/2019
PILM
PETITION INQUIRY LETTER ISSUED
12/04/2019
APET
ASSIGNED TO PETITION STAFF
12/03/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/03/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/14/2019
44EP
44(e) PETITION - RECEIVED
10/01/2019
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
10/01/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/17/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/23/2019
PUBO
PUBLISHED FOR OPPOSITION
07/23/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/03/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/15/2019
DOCK
ASSIGNED TO EXAMINER
06/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/01/2019
NWAP
NEW APPLICATION ENTERED
04/15/2019
Continuous trademark protection
Get notified about every new filing that threatens NAMVONA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.